A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

Clinical trial NCT05431088 · RECRUITING

Trial details

NCT number: NCT05431088
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2022-09-22
Primary completion: 2030-12-30
Enrollment: 389

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.